NYSEARCA:CMD - NYSE Arca -
80.37
-0.96 (-1.18%)
The current stock price of CMD is 80.37 null. In the past month the price decreased by -9.48%. In the past year, price increased by 60.13%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
SYK | STRYKER CORP | 31.4 | 145.92B | ||
MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
DXCM | DEXCOM INC | 53.81 | 34.68B | ||
RMD | RESMED INC | 26.21 | 34.03B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Cantel Medical Corp. engages in the development and manufacture of infection prevention products and services in the healthcare market. The company is headquartered in Little Falls, New Jersey and currently employs 3,669 full-time employees. The firm's operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies. The firm's Water Purification and Filtration segment includes water purification equipment and services, filtration and separation products, and disinfectant, sterilization and decontamination products and services. Its Healthcare Disposables segment includes single-use, infection prevention and control healthcare products. The firm's Dialysis segment includes medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates and other supplies for renal dialysis. The firm offers a range of filters utilizing hollow fiber membrane technology.
Cantel Medical
150 Clove Rd
Little Falls NEW JERSEY 07424 US
CEO: George L. Fotiades
Employees: 3669.0
Company Website: http://www.cantelmedical.com/
Phone: 19738907220.0
The current stock price of CMD is 80.37 null. The price decreased by -1.18% in the last trading session.
The exchange symbol of Cantel Medical is CMD and it is listed on the NYSE Arca exchange.
CMD stock is listed on the NYSE Arca exchange.
4 analysts have analysed CMD and the average price target is 63.24 null. This implies a price decrease of -21.31% is expected in the next year compared to the current price of 80.37. Check the Cantel Medical stock analysts ratings, price target forecast and up-and down grades for more detailed information.
Cantel Medical (CMD) has a market capitalization of 3.58B null. This makes CMD a Mid Cap stock.
Cantel Medical (CMD) currently has 3669.0 employees.
Cantel Medical (CMD) has a support level at 74.28 and a resistance level at 81.31. Check the full technical report for a detailed analysis of CMD support and resistance levels.
The Revenue of Cantel Medical (CMD) is expected to grow by 17.48% in the next year. Check the estimates tab for more information on the CMD EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
Cantel Medical (CMD) has a dividend yield of 0.13%. The yearly dividend amount is currently 0.11. Check the full fundamental report for a detailed analysis of CMD dividend history, reliability and sustainability.
The PE ratio for Cantel Medical (CMD) is 48.42. This is based on the reported non-GAAP earnings per share of 1.66 and the current share price of 80.37 null. Check the full fundamental report for a full analysis of the valuation metrics for CMD.
ChartMill assigns a technical rating of 5 / 10 to CMD. When comparing the yearly performance of all stocks, CMD is one of the better performing stocks in the market, outperforming 70.58% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to CMD. CMD has an average financial health and profitability rating.
Over the last trailing twelve months CMD reported a non-GAAP Earnings per Share(EPS) of 1.6600000000000001. The EPS decreased by -29.96% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 4.57% | ||
ROA | 2.56% | ||
ROE | 6.37% | ||
Debt/Equity | 0.9 |
ChartMill assigns a Buy % Consensus number of 65% to CMD. The Buy consensus is the average rating of analysts ratings from 4 analysts.
For the next year, analysts expect an EPS growth of 82.92% and a revenue growth 17.48% for CMD